Cdex, Inc. (fka CDEX)

[Viking65]

CDEX PARTNERS - SEC 10K Report:

http://www.sec.gov/Archives/edgar/data/1173738/000121465914001096/s21114010k.htm

Our partners continue to be invaluable in the development of the final form and function of our ValiMed G4 technology. On numerous occasions throughout 2013, our personnel have traveled to each site working with our partners in determining the “real world” needs, applications, and challenges of fully implementing VG4 technology. This effort should prove out to be a most crucial step in the process to insure a successful launch into the mainstream marketplace of the hospital pharmacy environment

Demand and interest in our VG4 technology is very high, and continues to grow. Through current relationships, attendance at numerous trade shows, our web site, and word of mouth throughout the industry, we are in negotiation for multiple placements which include; a university hospital, teaching hospitals, general hospitals, clinics, and children’s hospitals all around the country, and internationally. This new approach for CDEX, of having a few select hospitals as beta site partners, has proven to be a critical step which has provided the necessary data, and details for the development of the final product. Although this step has delayed the launch of VG4 platform, it has proven to be a vital tool for an anticipated successful future launch for the VG4.

Research and Development (“R&D”)

In 2014, we expect to continue the exploration and development of new capabilities for our VG4 technology, such as expanding the signature libraries of detectable drugs and improving multi-component capabilities. Additionally, we anticipate to partner with a major Midwestern university hospital to develop an oncology formulary, and possibly the detection of drugs in blood and/or urine, such as banned performance enhancing drugs, HGH, and HCG. If demand and budget allows we also expect to begin development research in creating a portable VG4 unit, which could be utilized to service the smaller hospitals, pain centers, and convalescent hospitals, in their fight against narcotics diversion.